Short-Acting Beta2-Agonists (SABAs) In Treatment Of Asthma Medical Video by Respiratory

Short-Acting Beta2-Agonists (SABAs) In Treatment Of Asthma

Rating: 0.0 out of 0 votes

Comments (0)

You need to have the Flash Player installed and a browser with JavaScript support.

Description Dr. Christopher Blanchette discusses findings that suggest children with asthma who use at least six cannisters of short-acting beta2-agonists per year are at increased risk of asthma exacerbation. Heidi Splete of the Global Medical News Network (GMNN) reports from the annual meeting of the American Academy of Allergy Asthma and Immunology.
Tags asthma, saba, short, acting, beta, agonist, blanchette, splete